Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Bio Farma ‘ready to mass-produce’ COVID-19 vaccine by year’s end

  • Rizki Fachriansyah


Jakarta   /   Thu, August 6 2020   /  01:00 am
State-Owned Enterprises (SOEs) Minister Erick Thohir during an inspection of phase three clinical trials for the Sinovac COVID-19 vaccine at PT Bio Farma in Bandung, West Java on Aug. 4.(Courtesy/National Economic and COVID-19 Recovery Committee)

State-Owned Enterprises Minister Erick Thohir, who also chairs the national economic and COVID-19 recovery committee, has claimed that state pharmaceutical holding company PT Bio Farma is ready to produce 250 million doses of the Sinovac candidate vaccine per year by the end of 2020. “I have ensured that Bio Farma is ready to produce 100 million doses of a COVID-19 vaccine per year, and by the end of the year will be able to produce 250 million doses per year,” Erick said during an inspection of Bio Farma’s laboratories and production facilities in Bandung, West Java, on Tuesday, as quoted in a statement. He said the committee had focused on doubling the availability of vaccines and therapies as they were crucial in accelerating the national recovery process. “Let’s maximize the clinical trials and production of the COVID-19 vaccine so the public co...